Joseph Savage, Jr., a partner in Goodwin's Securities Litigation & White Collar Defense Group, and Kate MacLeman, an associate in the firm's Litigation Department, write on the Food, Drug, and Cosmetic Act and its effect on penalties and heightened scrutiny. The duo also discuss allowing prosecutors to charge corporate employees with misdemeanors without having to prove personal participation or wrongful intent.